Thurston Springer Miller Herd & Titak Inc. Takes $45,000 Position in Cardinal Health, Inc. (NYSE:CAH)

Thurston Springer Miller Herd & Titak Inc. bought a new position in Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 461 shares of the company’s stock, valued at approximately $45,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Clearstead Trust LLC bought a new stake in Cardinal Health during the 4th quarter valued at approximately $25,000. Raleigh Capital Management Inc. boosted its position in shares of Cardinal Health by 4,466.7% during the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after acquiring an additional 268 shares during the last quarter. YHB Investment Advisors Inc. purchased a new position in Cardinal Health during the first quarter valued at $32,000. LRI Investments LLC purchased a new stake in Cardinal Health in the 1st quarter worth $32,000. Finally, Hexagon Capital Partners LLC boosted its holdings in shares of Cardinal Health by 53.6% during the 4th quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock valued at $34,000 after purchasing an additional 118 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of research reports. Citigroup cut their price target on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Robert W. Baird increased their price target on shares of Cardinal Health from $129.00 to $130.00 and gave the company an “outperform” rating in a report on Tuesday, July 9th. StockNews.com raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI cut their target price on Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Finally, Wells Fargo & Company dropped their price objective on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research note on Monday, April 29th. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $109.67.

Cardinal Health Stock Up 1.0 %

Shares of CAH traded up $1.01 during mid-day trading on Wednesday, hitting $100.53. 204,112 shares of the company traded hands, compared to its average volume of 2,138,231. The business has a 50 day moving average of $98.57 and a 200 day moving average of $103.32. The company has a market capitalization of $24.49 billion, a PE ratio of 44.23, a price-to-earnings-growth ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a 1-year low of $85.11 and a 1-year high of $116.04.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.